Teva Pharmaceuticals USA, Inc recalls Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications
- Products
-
- Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen
- Where it was sold
-
USA nationwide.
Nationwide
- Units affected
- 92,676 cartons
- About this recall
- Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62